Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.
Open | $1.240 |
Close | $1.240 |
Volume / Avg. | 129.678K / 598.339K |
Day Range | 1.215 - 1.290 |
52 Wk Range | 0.945 - 3.110 |
Market Cap | $112.411M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 3.41% |
Days to Cover | 11.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.
Other companies in Immunic’s space includes: Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and FibroGen (NASDAQ:FGEN).
The latest price target for Immunic (NASDAQ: IMUX) was reported by Brookline Capital on Friday, April 5, 2024. The analyst firm set a price target for 10.00 expecting IMUX to rise to within 12 months (a possible 700.00% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Immunic (NASDAQ: IMUX) is $1.25 last updated April 23, 2024 at 7:15 PM EDT.
There are no upcoming dividends for Immunic.
Immunic’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Immunic.
Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.